Trial Profile
Pharmacokinetics and tolerability of oxcarbazepine and a monohydroxy derivative of oxcarbazepine in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2011
Price :
$35
*
At a glance
- Drugs Oxcarbazepine (Primary) ; Monohydroxy derivative of oxcarbazepine
- Indications Partial epilepsies
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Novartis
- 11 Apr 2011 New trial record